This trip to Sydney is the first stop of GSPMED's 2024 overseas exhibition, and it is also our first trial in the Australian market.
Due to the impact of the COVID-19 since 2019,
the scale of AGHA EXPO with a history of more than 25 years has been reduced to 1/5 of the best period in the past, and the flow of people has also been greatly reduced.
Both local and foreign exhibitors have reported that the sales performance has declined seriously.
But this will not affect GSP's confidence in expanding its business.
We believe that as the shadow of the epidemic gradually dissipates and the demand for self-protection and reasonable exercise increases, our products will also have more sales opportunities in the Australian market.
